Demant A/S (CPH:DEMANT)
Denmark · Delayed Price · Currency is DKK 301.00
+1.80 (0.60%)
Sep 18, 2026, 4:59 PM CET
Demant Market Cap
Demant has a market cap or net worth of 63.48 billion as of September 18, 2026. Its market cap has increased by 25.85% in one year.
Market Cap
63.48B
Enterprise Value
82.34B
Revenue
24.63B
Ranking
n/a
PE Ratio
26.22
Stock Price
301.00
ChartMarket Cap Chart
Since November 21, 1995, Demant's market cap has increased from 2.12B to 63.48B, an increase of 2,895.85%. That is a compound annual growth rate of 11.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 63.48B | 38.48% |
| Dec 30, 2025 | 45.84B | -20.30% |
| Dec 30, 2024 | 57.52B | -10.34% |
| Dec 29, 2023 | 64.15B | 51.17% |
| Dec 30, 2022 | 42.43B | -47.09% |
| Dec 30, 2021 | 80.20B | 39.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.25T |
| Genmab | 135.04B |
| Coloplast | 94.21B |
| ALK-Abelló | 44.04B |
| H. Lundbeck | 41.78B |
| Zealand Pharma | 19.21B |
| Ambu A/S | 17.16B |
| Bavarian Nordic | 15.76B |